AHF Press Conference: Advocates Demand Gilead to Put Lives Before Profits at AIDS 2024
22 Julio 2024 - 1:00AM
Business Wire
Tuesday, July 23, 13:15 CEST Munich,
Germany, In-person and via Zoom
AIDS Healthcare Foundation (AHF) will host an in-person
and virtual press conference at the AHF booth (#111)
during the 2024 International AIDS Conference (AIDS 2024) on
Tuesday, July 23 at 13:15 CEST (7:15 a.m. US EDT) in Munich,
Germany, at the Messe München Convention Center and
virtually via Zoom.
During the press conference, public health advocates and experts
will reiterate how global access to affordable medicines is being
subverted by the pursuit of profit-at-all-cost strategy employed by
Gilead Sciences and other Big Pharma companies. Unabated corporate
greed keeps millions of people in low- and middle-income countries
from accessing lifesaving medicines they need to stay alive and
healthy.
WHAT:
AHF to host LIVE and VIRTUAL GREEDY
GILEAD PRESS CONFERENCE during the International AIDS
Conference 2024 (AIDS 2024).
WHEN:
Tuesday, July 23 at 13:15 CEST (7:15
a.m. US EDT) – Munich, Germany
WHERE:
AHF AIDS 2024 BOOTH 111 at Messe
München Convention Center and VIRTUALLY VIA ZOOM.
WHO:
Public health experts and
advocates:
- Dr. V. Sam Prasad, Country Program Director, AHF India
Cares
- Dr. Victor Popoola, Medical Manager, AHF Sierra
Leone
- Guillermina Alaniz, Director of Global Advocacy &
Policy, AHF
- John Farina, Associate Director of Advocacy, AHF
NEWS DESK NOTE & B-ROLL
VISUALS
Press conference will be live streamed
on Zoom & Facebook from the AHF AIDS 2024 conference booth.
Visit the AHF FACEBOOK page or ZOOM LINK to watch.
Visit www.gilead.org for more information about the Greedy Gilead
campaign.
MEDIA CONTACTS:
Denys Nazarov, Director of Global Policy
& Communications, AHF, +1.323.308.1829,
denys.nazarov@ahf.org
Brian Shepherd, Associate Director of
Global Communications, AHF, +1.808.382.8570,
brian.shepherd@ahf.org
"Gilead has harmed people living with HIV worldwide for two-plus
decades by securing continual patents, known as 'evergreening,' and
generating billions of dollars through monopolies on some of the
most effective and well-tolerated antiretroviral HIV drugs. There's
no better place than AIDS 2024 to make everyone aware and demand
that Gilead choose lives over its greedy tactics that limit access
to medicines people worldwide desperately need," said AHF Chief of
Global Advocacy & Policy Terri Ford. "As a leading global
HIV/AIDS organization with more than 2 million patients in care in
47 countries, AHF is taking a stand and calling out Gilead so that
governments and decision-makers everywhere put collective pressure
on it to prioritize lives over obscenely high profits."
Advocates will also highlight the fact that HIV/AIDS is not
over—as it remains a pandemic and a significant global public
health crisis responsible for 630,000 deaths every year globally.
According to UNAIDS, more than 39 million people were living with
HIV in 2022, including 1.3 million people who had newly acquired
the virus. Since the AIDS pandemic started, more than 40 million
people have died from AIDS-related illnesses.
AIDS Healthcare Foundation (AHF) is a global non-profit
organization providing cutting-edge medicine and advocacy to more
than 2 million people in 47 countries worldwide in Africa, the
Americas, the Asia/Pacific Region and Europe. We are currently the
largest non-profit provider of HIV/AIDS medical care in the world.
To learn more about AHF, please visit our website:
www.aidshealth.org, find us on Facebook:
www.facebook.com/aidshealth and follow us on Twitter:
@aidshealthcare and Instagram: @aidshealthcare
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240721281722/en/
Denys Nazarov, Director of Global Policy & Communications,
AHF, +1.323.308.1829, denys.nazarov@ahf.org Brian Shepherd,
Associate Director of Global Communications, AHF, +1.808.382.8570,
brian.shepherd@ahf.org